Cg-Vak Software & Exports Ltd. specializes in Computers - Software & Consulting within the Information Technology sector.
Cg-Vak Software & Exports Ltd., with Security Code 531489, is a leading player in the Computers - Software & Consulting industry, categorized under the Information Technology sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2023-10-01 | 2023-12-31 | 189.35 | 18.07 | 197.02 | 3.58 | - | 7.67 | -4.00 | 23.55 |
| 2023-10-01 | 2023-12-31 | 126.25 | 17.97 | 132.25 | 3.56 | - | 6.01 | -4.00 | 23.16 |
| 2023-07-01 | 2023-09-30 | 138.02 | 23.90 | 141.80 | 4.73 | - | 3.78 | -3.98 | 31.76 |
| 2023-07-01 | 2023-09-30 | 201.95 | 24.76 | 206.50 | 4.90 | - | 4.55 | -3.98 | 32.85 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 22% |
| 3 Years: | 22% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 21% |
| 3 Years: | 9% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 59% |
| 3 Years: | 22% |
| 1 Year: | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 17% |
| 3 Years: | 21% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 21% |
| 3 Years: | 10% |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 59% |
| 3 Years: | 22% |
| 1 Year: | 8% |
CG-VAK Software & Exports Ltd.'s Plant Extracts Division has achieved the prestigious ISO 17025 accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL), a constituent board of the Quality Council of India.
CG-VAK Software & Exports Ltd. has announced a strategic partnership with a leading global research firm to enhance its pharmaceutical development capabilities and accelerate the delivery of innovative drug products.
CG-VAK Software & Exports Ltd. has made a significant investment in an AI-driven drug discovery platform to empower its scientists with advanced tools and capabilities.
CG-VAK Software & Exports Ltd. has expanded its global presence with the establishment of a new research center in Europe, further strengthening its commitment to innovation and scientific collaboration.
